Canopy Growth (CGC) Gross Margin (2019 - 2025)

Canopy Growth (CGC) reported Gross Margin of 28.78% for Q4 2025, down 345.0% on a YoY basis from 11.75% in Q4 2024, and down 12.38% sequentially from 32.85% in Q3 2025.

Canopy Growth (CGC) Gross Margin (2019 - 2025) Analysis & Trends

Canopy Growth (CGC) has 7 years of Gross Margin data on file, last reported at 28.78% in Q4 2025.

  • For the quarter ending Q4 2025, Gross Margin fell 345.0% year-over-year to 28.78%; the trailing twelve-month figure through Dec 2025 stood at 29.39% (down 108.0% YoY), and the FY2026 full-year result was 111.97%, down 6483.0% from the prior year.
  • Gross Margin slipped to 28.78% in Q4 2025, from 32.85% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 44.31% in Q1 2022 to a low of 55.34% in Q1 2023.
  • A 5-year average of 14.0% and a median of 21.25% in 2024 frame the typical range for Gross Margin.
  • Peak annual rise in Gross Margin reached 9169 bps in 2021, while the deepest fall reached 13496 bps in 2021.
  • Tracing CGC's Gross Margin over 5 years: stood at 6.51% in 2021, then fell by 5 bps to 6.16% in 2022, then surged by 484 bps to 35.95% in 2023, then fell by 10 bps to 32.23% in 2024, then declined by 11 bps to 28.78% in 2025.
  • Business Quant data shows CGC's Gross Margin at 28.78% in Q4 2025, 32.85% in Q3 2025, and 25.01% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 49.52%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 71.66%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 62.93%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 82.93%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 32.97%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 98.31%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 57.26%
10 Canopy Growth 197.77 Mn -68.15 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 28.78%
Sep 30, 2025 32.85%
Jun 30, 2025 25.01%
Dec 31, 2024 32.23%
Sep 30, 2024 34.67%
Jun 30, 2024 34.78%
Mar 31, 2024 21.25%
Dec 31, 2023 35.95%
Sep 30, 2023 33.66%
Jun 30, 2023 18.05%
Mar 31, 2023 -55.34%
Dec 31, 2022 6.16%
Sep 30, 2022 -0.69%
Jun 30, 2022 -4.71%
Mar 31, 2022 44.31%
Dec 31, 2021 6.51%
Sep 30, 2021 -54.15%
Jun 30, 2021 20.00%
Mar 31, 2021 6.60%
Dec 31, 2020 141.46%